Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:976-982

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1999;34:976-982.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Ang II–Stimulated Superoxide Production Is Mediated via Phospholipase D in Human Vascular Smooth Muscle Cells

Rhian M. Touyz; Ernesto L. Schiffrin

From the Experimental Hypertension Laboratory, MRC Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal and Université de Montréal, Montreal, Quebec, Canada H2W 1R7.

Correspondence to Rhian M. Touyz, MD, PhD, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, Canada H2W 1R7. E-mail touyz{at}ircm.umontreal.ca

Abstract—Intracellular signaling events that mediate the long-term effects of Ang II in vascular smooth muscle cells are unclear, but oxidative stress may play an important role. This study examined the ability of Ang II to generate reactive oxygen species and investigated the putative role of phospholipase D (PLD)–dependent signaling pathways for its production in human vascular smooth muscle cells. In addition, we assessed whether redox-sensitive pathways influence Ang II–stimulated cell growth. Primary and low-passage cells (passages 1 to 4) derived from resistance arteries of subcutaneous gluteal biopsies from healthy subjects were studied. Oxidative stress was measured with the fluorescent probe 5-(and 6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (8 µmol/L), and the role of PLD was assessed with the PLD inhibitor D-erythro-sphingosine, dihydro (sphinganine) (10 µmol/L). To determine whether NADH/NADPH oxidase contributes to production of reactive oxygen species, Ang II–stimulated cells were pretreated with the specific flavoprotein inhibitor diphenylene iodinium (DPI) (10 µmol/L). DNA and protein synthesis were determined by [3H]thymidine and [3H]leucine incorporation, respectively. Ang II increased CM-H2DCFDA fluorescence, and this was inhibited by catalase (350 U/mL), indicating that the fluorescence signal was derived predominantly from H2O2. Ang II dose-dependently increased H2O2 production (Emax=57.6±1.7 nmol/L, pD2=7.7±0.06) and PLD activation (Emax=207±3.3% of control, pD2=7.7±0.5). H2O2 effects were evident within 1 hour, and maximal PLD activation occurred within 40 minutes after stimulation. DPI inhibited (P<0.01) Ang II–stimulated responses. PLD inhibition significantly attenuated (P<0.05) Ang II–elicited H2O2 production (Emax=29±5 nmol/L). DPI and sphinganine inhibited Ang II–induced DNA and protein synthesis. These data indicate that in vascular smooth muscle cells from human peripheral resistance arteries, Ang II increases H2O2 generation via PLD-dependent, NADH/NADPH oxidase–sensitive pathways. These cascades may function as second messengers in long-term Ang II–mediated growth-signaling events.


Key Words: oxidative stress • superoxide anions • intracellular signaling • vascular hypertrophy




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. E. Herbert, Y. Mistry, R. Hastings, T. Poolman, L. Niklason, and B. Williams
Angiotensin II-Mediated Oxidative DNA Damage Accelerates Cellular Senescence in Cultured Human Vascular Smooth Muscle Cells via Telomere-Dependent and Independent Pathways
Circ. Res., February 1, 2008; 102(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Choi, T. L. Leto, L. Hunyady, K. J. Catt, Y. S. Bae, and S. G. Rhee
Mechanism of Angiotensin II-induced Superoxide Production in Cells Reconstituted with Angiotensin Type 1 Receptor and the Components of NADPH Oxidase
J. Biol. Chem., January 4, 2008; 283(1): 255 - 267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Bechara, X. Wang, H. Chai, P. H. Lin, Q. Yao, and C. Chen
Growth-related oncogene-{alpha} induces endothelial dysfunction through oxidative stress and downregulation of eNOS in porcine coronary arteries
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3088 - H3095.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Zemse, R. H. P. Hilgers, and R. C. Webb
Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, T. Shimosawa, H. Matsui, F. Meng, S. C. Supowit, D. J. DiPette, K. Ando, and T. Fujita
Adrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activity
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1714 - H1721.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells
Hypertension, October 1, 2006; 48(4): 534 - 540.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. E. Clempus and K. K. Griendling
Reactive oxygen species signaling in vascular smooth muscle cells
Cardiovasc Res, July 15, 2006; 71(2): 216 - 225.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Hunyady and K. J. Catt
Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II
Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
N. Ardanaz and P. J. Pagano
Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction.
Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. E. Jalil, A. Perez, M. P. Ocaranza, J. Bargetto, A. Galaz, and S. Lavandero
Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme Levels
Hypertension, December 1, 2005; 46(6): 1362 - 1367.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. E. Ullian, A. K. Gelasco, W. R. Fitzgibbon, C. N. Beck, and T. A. Morinelli
N-Acetylcysteine Decreases Angiotensin II Receptor Binding in Vascular Smooth Muscle Cells
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2346 - 2353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero
AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. L. Schiffrin and R. M. Touyz
Calcium, Magnesium, and Oxidative Stress in Hyperaldosteronism
Circulation, February 22, 2005; 111(7): 830 - 831.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yang, L. D. Asico, P. Yu, Z. Wang, J. E. Jones, R.-k. Bai, D. R. Sibley, R. A. Felder, and P. A. Jose
D5 dopamine receptor regulation of phospholipase D
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H55 - H61.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Zhang, K. Rhinehart, G. Solis, J. Pittner, W. Lee-Kwon, W. J. Welch, C. S. Wilcox, and T. L. Pallone
Chronic ANG II infusion increases NO generation by rat descending vasa recta
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H29 - H36.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Williams, J. S. Pollock, and D. M. Pollock
Arterial Pressure Response to the Antioxidant Tempol and ETB Receptor Blockade in Rats on a High-Salt Diet
Hypertension, November 1, 2004; 44(5): 770 - 775.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. M. Boustany, K. Bharadwaj, A. Daugherty, D. R. Brown, D. C. Randall, and L. A. Cassis
Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R943 - R949.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. H. Endemann and E. L. Schiffrin
Endothelial Dysfunction
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1983 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Zhang, K. Rhinehart, W. Kwon, E. Weinman, and T. L. Pallone
ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H773 - H781.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Yoshimoto, N. Fukai, R. Sato, T. Sugiyama, N. Ozawa, M. Shichiri, and Y. Hirata
Antioxidant Effect of Adrenomedullin on Angiotensin II-Induced Reactive Oxygen Species Generation in Vascular Smooth Muscle Cells
Endocrinology, July 1, 2004; 145(7): 3331 - 3337.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. T. Andresen, G. G. Romero, and E. K. Jackson
AT2 Receptors Attenuate AT1 Receptor-Induced Phospholipase D Activation in Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 425 - 431.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
G. Du, P. Huang, B. T. Liang, and M. A. Frohman
Phospholipase D2 Localizes to the Plasma Membrane and Regulates Angiotensin II Receptor Endocytosis
Mol. Biol. Cell, March 1, 2004; 15(3): 1024 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Bleeke, H. Zhang, N. Madamanchi, C. Patterson, and J. E. Faber
Catecholamine-Induced Vascular Wall Growth Is Dependent on Generation of Reactive Oxygen Species
Circ. Res., January 9, 2004; 94(1): 37 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ritz and V. Haxsen
Angiotensin II and Oxidative Stress: An Unholy Alliance
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2985 - 2987.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Lassegue and R. E. Clempus
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. P. Didion and F. M. Faraci
Angiotensin II Produces Superoxide-Mediated Impairment of Endothelial Function in Cerebral Arterioles
Stroke, August 1, 2003; 34(8): 2038 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Finckenberg, K. Inkinen, J. Ahonen, S. Merasto, M. Louhelainen, H. Vapaatalo, D. Muller, D. Ganten, F. Luft, and E. Mervaala
Angiotensin II Induces Connective Tissue Growth Factor Gene Expression via Calcineurin-Dependent Pathways
Am. J. Pathol., July 1, 2003; 163(1): 355 - 366.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Desideri, M. C. Bravi, M. Tucci, G. Croce, M. C. Marinucci, A. Santucci, E. Alesse, and C. Ferri
Angiotensin II Inhibits Endothelial Cell Motility Through an AT1-Dependent Oxidant-Sensitive Decrement of Nitric Oxide Availability
Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1218 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. E. Cifuentes and P. J. Pagano
c-Src and Smooth Muscle NAD(P)H Oxidase: Assembling a Path to Hypertrophy
Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 919 - 921.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R.M. Touyz, G. Yao, and E.L. Schiffrin
c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 981 - 987.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. D. Frank, M. Mifune, T. Inagami, M. Ohba, T. Sasaki, S. Higashiyama, P. J. Dempsey, and S. Eguchi
Distinct Mechanisms of Receptor and Nonreceptor Tyrosine Kinase Activation by Reactive Oxygen Species in Vascular Smooth Muscle Cells: Role of Metalloprotease and Protein Kinase C-{delta}
Mol. Cell. Biol., March 1, 2003; 23(5): 1581 - 1589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. N. Muller, E. Shagdarsuren, J.-K. Park, R. Dechend, E. Mervaala, F. Hampich, A. Fiebeler, X. Ju, P. Finckenberg, J. Theuer, et al.
Immunosuppressive Treatment Protects Against Angiotensin II-Induced Renal Damage
Am. J. Pathol., November 1, 2002; 161(5): 1679 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. N. Seshiah, D. S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K. K. Griendling
Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators
Circ. Res., September 6, 2002; 91(5): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, M. T. Quinn, P. J. Pagano, and E. L. Schiffrin
Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II
Circ. Res., June 14, 2002; 90(11): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Hirota, A. Ichihara, Y. Koura, M. Hayashi, and T. Saruta
Phospholipase D Contributes to Transmural Pressure Control of Prorenin Processing in Juxtaglomerular Cell
Hypertension, February 1, 2002; 39(2): 363 - 367.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz, G. He, M. El Mabrouk, and E. L. Schiffrin
p38 MAP Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin II in SHR But Not in WKY
Hypertension, February 1, 2001; 37(2): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. C. Luft
Workshop: Mechanisms and Cardiovascular Damage in Hypertension
Hypertension, February 1, 2001; 37(2): 594 - 598.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. J. Thannickal and B. L. Fanburg
Reactive oxygen species in cell signaling
Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. K. Griendling, D. Sorescu, B. Lassegue, and M. Ushio-Fukai
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology
Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2175 - 2183.
[Abstract] [Full Text] [PDF]